Cannabis sativa: The plant that can induce unwanted effects and also treat them;Cannabis sativa: A planta que pode produzir efeitos indesejáveis e também tratá-los

Revista Brasileira de Psiquiatria

Volumn 32, Issue SUPPL. 1, 2010, Pages

  Zuardi, Antonio Waldo ^a,b   Crippa, José Alexandre S ^a,b   Hallak, Jaime E C ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Institute for Translational Medicine (INCT TM CNPq)   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS;

BIBLIOMETRICS; EDITORIAL; HUMAN; MEDICAL RESEARCH; STATISTICS;

BIBLIOMETRICS; BIOMEDICAL RESEARCH; CANNABINOIDS; CANNABIS; HUMANS;

EID: 78650624740     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res. 2006;39(4):421-9.
2. Zuardi AW. History of cannabis as a medicine: a review. Rev Bras Psiquiatr. 2006;28(2):153-7.
3. Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol. 2009;24(7):515-23.
4. Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr. 2008;30(3):271-80.
5. Crippa JAS, Zuardi AW, Hallak JEC. Therapeutical use of the cannabinoids in psychiatry. Rev Bras Psiquiatr. 2010;32(Suppl I):S56-66.
6. Saito VM, Wotjak CT, Moreira FA. Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? Rev Bras Psiquiatr. 2010;32(Suppl I):S7-14.
7. Solowij N, Pesa N. Cognitive abnormalities and cannabis use. Rev Bras Psiquiatr. 2010;32(Suppl I):S31-40
8. Budney AJ, Vandrey RG, Stanger C. Pharmacological and psychosocial interventions for cannabis use disorders. Rev Bras Psiquiatr. 2010;32(Suppl I):S46-55.